RAPT Therapeutics gets grant for inhibiting hematopoietic progenitor kinase 1 using pyrazole pyrimidine compounds

17h ago, source: Pharmaceutical Technology

Discover the groundbreaking patent by RAPT Therapeutics Inc for pyrazole pyrimidine compounds targeting HPK1. Explore its potential in cancer treatment and beyond.

What Makes RAPT Therapeutics (RAPT) an Investment Choice?

27d ago, source: InvestingChannel on MSN

TimesSquare Capital U.S. Small Cap Growth Strategy featured stocks like RAPT Therapeutics, Inc. (NASDAQ:RAPT) in the fourth ...

Hold Rating on RAPT Therapeutics Amid Promising Data and Regulatory Uncertainties

6d ago, source: Business Insider

Begin your TipRanks Premium journey today. RAPT Therapeutics (RAPT) Company Description: Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on ...

RAPT Therapeutics Inc Ordinary Shares

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

RAPT Therapeutics Stock (NASDAQ:RAPT), Analyst Ratings, Price Targets, Predictions

9d ago, source: Benzinga.com

$8.13 404.31% HC Wainwright & Co.

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: Business Insider

SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing ...

RAPT Therapeutics Inc.

22d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

RLAY Relay Therapeutics, Inc.

6d ago, source: Seeking Alpha

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule ...